1. Home
  2. MMYT vs TVTX Comparison

MMYT vs TVTX Comparison

Compare MMYT & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MakeMyTrip Limited

MMYT

MakeMyTrip Limited

N/A

Current Price

$60.51

Market Cap

4.7B

ML Signal

N/A

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

N/A

Current Price

$65.62

Market Cap

5.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MMYT
TVTX
Founded
2000
N/A
Country
India
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
5.3B
IPO Year
2010
2013

Fundamental Metrics

Financial Performance
Metric
MMYT
TVTX
Price
$60.51
$65.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
13
Target Price
$101.00
$40.62
AVG Volume (30 Days)
648.5K
1.6M
Earning Date
05-20-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
92.89
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.83
$44.76
Revenue Next Year
$17.24
$35.51
P/E Ratio
$107.67
N/A
Revenue Growth
N/A
N/A
52 Week Low
$32.67
$17.05
52 Week High
$103.56
$66.24

Technical Indicators

Market Signals
Indicator
MMYT
TVTX
Relative Strength Index (RSI) 57.96 67.55
Support Level $53.09 $53.76
Resistance Level $60.67 $66.24
Average True Range (ATR) 2.17 2.47
MACD -0.22 0.41
Stochastic Oscillator 30.97 95.72

Price Performance

Historical Comparison
MMYT
TVTX

About MMYT MakeMyTrip Limited

MakeMyTrip Ltd is an online travel company, which provides online booking solutions for day-to-day travel needs. The company's operating segment includes Air ticketing; Hotels and packages; Bus ticketing and Others. It generates maximum revenue from the Hotels and packages segment. The Hotels and packages segments include internet-based platforms, call-centers, and branch offices, which provide holiday packages and hotel reservations. Its Air ticketing segment includes internet-based platforms, provides the facility to book domestic and international air tickets. Geographically, it derives a majority of revenue from India and also has a presence in the United States; South East Asia; Europe, and other countries.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

Share on Social Networks: